To worry is the situation abroad, especially in Europe. The World Health Organization has raised the alarm: “For the first time in months, Europe has seen an increase in the number of weekly cases of coronaviruses last week, just as countries began to ease restrictions aimed at curbing their spread. Every day in the Old Continent there are about 20 thousand new cases and over 700 new deaths, indicated the director of the European section of the WHO, Hans Kluge.
Of course, thethe epicenter of the diffusion still remains the Americas, with the United States having set a new record with almost 36 thousand new infections in one day. Nonetheless, President Donald Trump has decided to cut federal funds for 13 sites where Covid-19 tests are conducted. Seven of these sites are also in Texas, one of the states that experiences a surge in coronaviruses. It is no coincidence that the decision was also criticized by the Texan Republican senators Ted Cruz and John Cornyn, who thus entered the crawl space of controversies raised by Trump when he informed Tulsa that he had ordered to slow down the tests to reduce the numbers of the contagions that generate anxiety.
WHO Director-General Tedros Adhanom Ghebreyesus, speaking by videoconference to the European Parliament, confirmed that “the global situation is worsening, we expect to reach 10 and a half million cases next week. “While his colleague Kluge, head of the European section of the UN agency, wanted to specify in a press conference from Copenhagen that in Europe” thirty countries have witnessed increases in new cumulative cases in the past two weeks. “And he warned that” in 11 of these countries, accelerated transmission has led to a very significant recovery that, if left unchecked, will bring healthcare systems back to the brink of collapse”.
On the research front, after months of news on drugs capable of fighting Covid, the effectiveness of which in many cases was later denied by the first test results, today the green light comes to a therapy with the use of Remdesivir. The European Medicines Agency (Ema) has in fact given its assent (which must be ratified by the European Commission) to the use of the drug and this will allow it to be placed on the market. The Chmp, which deals with human medicines, has therefore recommended the conditional approval of Remdesivir, the antiviral initially studied against Ebola. The therapy, the agency’s statement said, will be indicated for the treatment of Covid-19 in adults and adolescents from 12 years of age with pneumonia that requires respiratory support.